Adverse Event | Placebo | AZD7594 58 μg | AZD7594 250 μg | AZD7594 800 μg |
---|---|---|---|---|
N = 52 | N = 34 | N = 34 | N = 34 | |
n (%) | n (%) | n (%) | n (%) | |
Patients with any AE | 17 (32.69) | 13 (38.24) | 9 (26.47) | 12 (35.29) |
Nasopharyngitis | 8 (15.38) | 4 (11.76) | 2 (5.88) | 4 (11.76) |
Headache | 0 (0.00) | 0 (0.00) | 3 (8.82) | 2 (5.88) |
Gastroenteritis | 0 (0.00) | 3 (8.82) | 0 (0.00) | 0 (0.00) |
Diarrhoea | 0 (0.00) | 0 (0.00) | 0 (0.00) | 3 (8.82) |
Cough | 1 (1.92) | 2 (5.88) | 0 (0.00) | 0 (0.00) |
Dyspnoea | 2 (3.85) | 0 (0.00) | 0 (0.00) | 0 (0.00) |